Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Deaths stop drug trial
About the author: 

A trial of the drug fialuridine (FIAU) on hepatitis sufferers has been stopped after several died and others became seriously ill

A trial of the drug fialuridine (FIAU) on hepatitis sufferers has been stopped after several died and others became seriously ill.

The trial was being managed by the US National Institutes of Health (NIH) with pharmaceutical giant Eli Lilly, which was marketing the new drug.

One man in the trial has started proceedings against the NIH and Oclassen Pharmaceuticals, a small drugs company based in California that developed the drug.

A lawsuit against Eli Lilly is pending, and more are expected.

Bristol Meyers dropped their license for the drug in 1988 after unsuccessful animal studies. Oclassen took it on after their research showed it could be developed to treat chronic hepatitis B. After a successful 10 day trial, the FDA granted Oclassen approval to carry out a four week trial among 24 patients without HIV infection. Various doses were administered; those on the middle doses showed a remarkable improvement. On the strength of that, Eli Lilly agreed to pay $7.5m to share the development and marketing rights.

However, four months after the trial ended, a 60 year old trial member died from liver failure. Another trial member reported tingling in his feet, and two more reported serious side effects.

Within a month, five more trial members had died, two after receiving liver transplants, and two more were gravely ill.

The FDA concluded that there was no possibility that these reactions could have been detected in animal studies or short studies on patients.


You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved